Gold Down Over 1%; Salarius Pharmaceuticals Shares Surge
1. SLRX surged 159% to $4.04 after merger news. 2. Broader market mixed; Dow up, NASDAQ down 0.79%. 3. Consumer inflation expectations steady at 3% for December.
1. SLRX surged 159% to $4.04 after merger news. 2. Broader market mixed; Dow up, NASDAQ down 0.79%. 3. Consumer inflation expectations steady at 3% for December.
The 159% surge indicates high investor confidence post-merger, paralleling past merger successes.
The merger significantly boosts SLRX's market presence and investor sentiment.
The immediate positive response from investors suggests heightened short-term interest.